|Data Element ID:||DE315|
|Name:||Stage event originated|
|Version:||Hospital Version 1.1, Hospital Version 1.2|
|Data Element ISO Name:||Event_Medication-Stage_Origination,CD|
|Definition:||The stage in the process the event originated.|
|Question:||At what stage in the process did the event originate, regardless of the stage at which it was discovered?|
|Form Name:||Medication or Other Substance|
|Setting:||Hospitals, including outpatient pharmacies and outpatient departments located within the hospital|
|Comments:||None defined at this time|
|Description of Change:||Changed Maximum Length of characters for free text from "500" to "2000"|
|Go-To Logic:||Refer to Common Formats Flow Charts|
|Guide For Use:||
Purchasing' includes purchasing for stock or for a particular patient.
'Storing' includes maintaining the substance under special environmental conditions and in accordance with appropriate security requirements.
'Prescribing/ordering' means the issuance of an order by an authorized professional for the delivery or administration of a substance to a patient. Prescribing/ordering may be done in writing, verbally or through an electronic order entry system.
'Transcribing' includes documenting verbal orders in writing or electronically, entering written orders into an electronic system, and copying orders for separate uses.
'Preparing' includes taking substances from stock, manipulating them, compounding, and measuring and apportioning doses, such as the filling of cartridges and unit-dose syringes.
'Dispensing' includes assuring accurate labeling of the prepared substance, issuance of the substance from the pharmacy, and delivery by pharmacy personnel to the patient care area.
'Administering' generally occurs in a patient care area and includes checking orders and patient identity and delivering the substance to the patient either by oral ingestion or by direct application, such as by injection, insertion, or topical application, or with the use of indwelling lines, tubes or catheters.
'Monitoring' includes measuring and observing to determine the presence or absence of the desired effect of the substance administered and to detect any unintended adverse effects.
|HL7 Data Type:||Concept Descriptor (CD)|
|Maximum Length:||5 (2000 for free text associated with 'Other: Please specify' response.)|
|Answer Code||Answer ID||Answer Value||Code System||Code System Name|
|A1380||a||Purchasing||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1383||b||Storing||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1386||c||Prescribing/ordering||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1389||d||Transcribing||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1392||e||Preparing||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1395||f||Dispensing||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1398||g||Administering||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A1401||h||Monitoring||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|A66||j||Other: Please specify||2.16.840.1.113883.3.263.1.12||AHRQ Common Formats|
|Until Date:||- -|
|Source:||Agency for Healthcare Research and Quality|
|Submitting Organization:||Agency for Healthcare Research and Quality (AHRQ)|
|Date of Submission:||- -|
|Responsible Organization:||Agency for Healthcare Research and Quality (AHRQ)|
|Creator:||Amy Helwig, MD, MS|
|Data Steward:||Agency for Healthcare Research and Quality (AHRQ)|
|References:||No specific reference at this time|
|Rationale for Change:||Increased narrative field size to accommodate more information|
|Administrative Status Date:||04/03/2012|